SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
ESAB Corporation (ESAB) trades at a trailing P/E of 27.6, forward P/E of 18.0. Trailing earnings yield is 3.63%, forward earnings yield 5.56%. PEG 0.32 (Peter Lynch undervalued ≤1.0). Graham Number is $55.12.
Criteria proven by this page:
- VALUE (58/100, Partial) — mixed signals — some valuation metrics are favorable while others are stretched.
- Forward P/E 18.0 (down from trailing 27.6) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 0.32 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 3.63% — roughly competitive with bond yields (~4.3%), moderate risk-reward. Forward yield improves to 5.56% as earnings recover.
- Analyst consensus target $150.25 (+44.2% upside) — significant upside potential according to Wall Street analysts.
Overall SharesGrow Score: 66/100 with 2/7 criteria passed.
SharesGrow 7-Criteria Score
~
VALUE
58/100
Price-to-Earnings & upside
Proven by this page
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — ESAB
Valuation Multiples
P/E (TTM)27.6
Forward P/E18.0
PEG Ratio0.32
Forward PEG0.32
P/B Ratio2.89
P/S Ratio2.19
EV/EBITDA15.0
Per Share Data
EPS (TTM)$3.72
Forward EPS (Est.)$5.79
Book Value / Share$36.29
Revenue / Share$46.64
FCF / Share$3.50
Yields & Fair Value
Earnings Yield3.63%
Forward Earnings Yield5.56%
Dividend Yield0.39%
Graham Number$55.12
SharesGrow IV$127.07 (+22%)
Analyst Target$150.25 (+44.2%)
Historical Valuation
| Year |
P/E (TTM) |
PEG Ratio |
P/B Ratio |
P/S Ratio |
Dividend Yield |
| 2019 |
17.3 |
0.00 |
1.14 |
1.34 |
- |
| 2020 |
19.1 |
-2.11 |
1.20 |
1.54 |
- |
| 2021 |
12.8 |
0.26 |
1.22 |
1.24 |
- |
| 2022 |
12.6 |
-2.60 |
2.09 |
1.09 |
0.21% |
| 2023 |
25.4 |
-2.71 |
3.25 |
1.88 |
0.26% |
| 2024 |
27.4 |
0.94 |
4.10 |
2.64 |
0.23% |
| 2025 |
30.0 |
-2.05 |
3.14 |
2.40 |
0.32% |
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2019 |
$2.88 |
$2.25B |
$172.91M |
7.7% |
| 2020 |
$2.62 |
$1.95B |
$157.41M |
8.1% |
| 2021 |
$3.92 |
$2.43B |
$235.11M |
9.7% |
| 2022 |
$3.72 |
$2.59B |
$223.75M |
8.6% |
| 2023 |
$3.36 |
$2.77B |
$203.73M |
7.3% |
| 2024 |
$4.31 |
$2.74B |
$264.84M |
9.7% |
| 2025 |
$3.72 |
$2.84B |
$226.77M |
8% |
Analyst Estimates
| Year |
EPS (Avg) |
EPS Range |
Revenue (Avg) |
Revenue Range |
Analysts |
| 2026 |
$5.82 |
$5.77 – $6.01 |
$2.92B |
$2.88B – $3B |
6 |
| 2027 |
$6.51 |
$6.05 – $7.23 |
$3.06B |
$2.93B – $3.3B |
5 |
| 2028 |
$7.27 |
$7.08 – $7.62 |
$3.23B |
$3.22B – $3.23B |
1 |
| 2029 |
$8.11 |
$7.89 – $8.49 |
$3.41B |
$3.34B – $3.53B |
1 |
